Targeted radionuclide therapy in combined-modality regimens

MR Gill, N Falzone, Y Du, KA Vallis - The Lancet Oncology, 2017 - thelancet.com
Targeted radionuclide therapy (TRT) is a branch of cancer medicine concerned with the use
of radioisotopes, radiolabelled molecules, nanoparticles, or microparticles that either …

[HTML][HTML] Current status and future perspectives on treatment of liver metastasis in colorectal cancer

A Bandar, M Hussain, NK Kim - Oncology reports, 2017 - spandidos-publications.com
Liver metastasis is the most common site of colorectal cancer (CRC) metastasis.
Approximately half of all colorectal cancer patients will develop liver metastases. Although …

[HTML][HTML] First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE …

HS Wasan, P Gibbs, NK Sharma, J Taieb… - The Lancet …, 2017 - thelancet.com
Background Data suggest selective internal radiotherapy (SIRT) in third-line or subsequent
therapy for metastatic colorectal cancer has clinical benefit in patients with colorectal liver …

[HTML][HTML] S3-leitlinie–kolorektales karzinom

W Schmiegel, B Buchberger… - Zeitschrift für …, 2017 - thieme-connect.com
2.1 Geltungsbereich und Zweck 2.1. 1. Zielsetzung und Fragestellung Das Kolorektale
Karzinom (KRK) ist mit etwa 64 000 Neuerkrankungen und ca. 26 000 Todesfällen pro Jahr …

[PDF][PDF] Prevention and treatment of complications of selective internal radiation therapy: expert guidance and systematic review

B Sangro, D Martínez‐Urbistondo, L Bester… - …, 2017 - Wiley Online Library
Selective internal radiation therapy (or radioembolization) by intra‐arterial injection of
radioactive yttrium‐90‐loaded microspheres is increasingly used for the treatment of …

Radioembolization-induced liver disease: a systematic review

MN Braat, KJ van Erpecum… - European journal of …, 2017 - journals.lww.com
Radioembolization (RE) is a relatively novel treatment modality for primary and secondary
hepatic malignancies. Microspheres embedded with a β-emitting radioisotope are injected …

Long-term outcomes of phase 1 and 2 studies of SBRT for hepatic colorectal metastases

A McPartlin, A Swaminath, R Wang, M Pintilie… - International Journal of …, 2017 - Elsevier
Purpose To report mature outcomes of prospective phase 1 and 2 studies of stereotactic
body radiation therapy (SBRT) for the treatment of colorectal liver metastases (CLMs) …

Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: a case-matched comparison …

PB Olthof, J Huiskens, DA Wicherts, PE Huespe… - Surgery, 2017 - Elsevier
Background Associating liver partition and portal vein ligation for staged hepatectomy
(ALPPS) allows the resection of colorectal liver metastases with curative intent which would …

Long-term hepatotoxicity of yttrium-90 radioembolization as treatment of metastatic neuroendocrine tumor to the liver

YK Su, RV Mackey, A Riaz, VL Gates… - Journal of Vascular and …, 2017 - Elsevier
Purpose To determine long-term hepatotoxicity of yttrium-90 (90 Y) radioembolization in
patients treated for metastatic neuroendocrine tumor (mNET) and evaluate if imaging and …

Radioembolization of colorectal liver metastases: indications, technique, and outcomes

FE Boas, L Bodei, CT Sofocleous - Journal of Nuclear Medicine, 2017 - Soc Nuclear Med
Liver metastases are a major cause of death from colorectal cancer. Intraarterial therapy
options for colorectal liver metastases include chemoinfusion via a hepatic arterial pump or …